PlainRecalls
FDA Drug Low Class III Terminated

Prempro (Conjugated Estrogen/Medroxyprogesterone Acetate) tablets 0.625 mg/5.0 mg, 1 blister card containing 28 tablets, Rx only, Wyeth Pharmaceuticals Inc., Philadelphia, PA 1910, NDC 0046-0975-11

Reported: July 10, 2013 Initiated: May 31, 2013 #D-631-2013

Product Description

Prempro (Conjugated Estrogen/Medroxyprogesterone Acetate) tablets 0.625 mg/5.0 mg, 1 blister card containing 28 tablets, Rx only, Wyeth Pharmaceuticals Inc., Philadelphia, PA 1910, NDC 0046-0975-11

Reason for Recall

Failed Dissolution Specifications: Pfizer Inc. (Pfizer) is recalling PREMPRO (conjugated estrogens/medroxyprogesterone acetate tablets) because certain lots for this product may not meet the specification for conjugated estrogens dissolution.

Details

Recalling Firm
Pfizer Inc.
Units Affected
135,520 blister cards
Distribution
Nationwide and Puerto Rico
Location
New York, NY

Frequently Asked Questions

What product was recalled?
Prempro (Conjugated Estrogen/Medroxyprogesterone Acetate) tablets 0.625 mg/5.0 mg, 1 blister card containing 28 tablets, Rx only, Wyeth Pharmaceuticals Inc., Philadelphia, PA 1910, NDC 0046-0975-11. Recalled by Pfizer Inc.. Units affected: 135,520 blister cards.
Why was this product recalled?
Failed Dissolution Specifications: Pfizer Inc. (Pfizer) is recalling PREMPRO (conjugated estrogens/medroxyprogesterone acetate tablets) because certain lots for this product may not meet the specification for conjugated estrogens dissolution.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 10, 2013. Severity: Low. Recall number: D-631-2013.